Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi Case Report, J Otol Rhinol Vol: 1 Issue: 3
Treatment of Recurrent Vocal Cord Granuloma with Percutaneous Steroid Injection
| Kurt Nelson1 and John Schweinfurth2* | |
| 1University of Mississippi School of Medicine, USA | |
| 2Department of Otolaryngology and Communicative Sciences, University of Mississippi Medical Center, USA | |
| Corresponding author : John Schweinfurth, M.D Department of Otolaryngology and Communicative Sciences, University of Mississippi Medical Center, 2500 North State Street, Jackson, MS 39216, USA Tel: 601-984-5160; Fax: 601-984-5085 E-mail: jschweinfurth@umc.edu |
|
| Received: September 05, 2012 Accepted: November 02, 2012 Published: November 05, 2012 | |
| Citation: Nelson K, Schweinfurth J (2012) Treatment of Recurrent Vocal Cord Granuloma with Percutaneous Steroid Injection. J Otol Rhinol 1:3. doi:10.4172/2324-8785.1000105 |
Abstract
Treatment of Recurrent Vocal Cord Granuloma with Percutaneous Steroid Injection
Vocal cord granulomas are areas of chronic inflammation, usually located near the vocal process, caused by a variety of conditions such as intubation, gastroesophageal reflux disease, and vocal abuse. They are often difficult to eradicate. Treatments range from conservative management using anti-reflux medications, inhaled steroids, and voice therapy, to more invasive measures such as surgical excision, botulinum toxin injection, and steroid injection. Surgical treatment often leads to a high rate of recurrence. Botulinum toxin injections have shown promise in preliminary studies, but are not appropriate for all patients due to potential adverse effects. Percutaneous steroid injection offers a safe, minimally invasive, yet effective method of treating and preventing recurrence of both primary and recurrent vocal cord granulomas.
This paper reports successful treatment of a recurrent vocal cord granuloma using percutaneous steroid injection in a patient who failed both medical management and multiple surgical excisions. Complete resolution was seen two months after the second steroid injection. The patient has remained disease free one year from the final treatment, maintained only on daily proton pump inhibitor therapy. This case demonstrates there are multiple options available to treat this disease, and more prospective research is needed to establish a consistent treatment algorithm for all subsets of patients.
